Mednet Logo
HomeHematologyQuestion

What is your approach in a transplant-eligible patient with relapsed classical Hodgkin lymphoma who has an area of refractory disease after salvage chemotherapy?

3 Answers
Mednet Member
Mednet Member
Medical Oncology · University of Maryland Cancer Center

The goal here, especially in Hodgkin's lymphoma, is to achieve complete metabolic remission (CMR) by PET before high dose chemotherapy and autoSCT as data is clear in terms of difference in the outcome in favor of patients achieving CMR vs. those who achieved < CMR. So I would do what it takes to ac...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · UCSD Radiation Oncology

In relapsed or refractory HL, if there is a single site or low volume active disease after salvage chemotherapy, I strongly recommend pre-transplant RT to that site prior to auto-SCT. As mentioned above, the best outcomes for auto-SCT are in patients who go in with CMR to salvage therapy prior to tr...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · Siri Onclogy and hematology Infusion Service

If this patient has refractory disease (had no response or even progression, not less than PR), I would try an alternative therapy. I would avoid chemotherapy, as the chances of an encouraging response and transplant, are very low and any long term response low. There are so many alternative therapi...

Register or Sign In to see full answer